查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2132536

RNAi技術市場規模、佔有率和趨勢分析報告：按產品/服務、應用、最終用途、地區和細分市場預測（2026-2033年）

RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

RNAi技術市場概述

全球 RNAi 技術市場預計到 2025 年將達到 33 億美元，到 2026 年將成長到 37 億美元，到 2033 年將達到 95 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 14.6%。

北美在全球市場中處於領先地位，預計到 2025 年將佔據 38.3% 的最大銷售佔有率。這一市場成長歸因於自體免疫疾病、罕見疾病和癌症在全球日益普遍。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 產業分析工具

第4章：依產品/服務進行業務分析

  • RNAi技術市場：產品與服務趨勢分析
  • 產品
  • 服務

第5章：按應用程式進行業務分析

  • RNAi技術市場：基於應用的趨勢分析
  • 藥物發現與開發
  • 功能基因體學
  • 其他

第6章：依最終用途進行業務分析

  • RNAi技術市場：依最終用途分類的趨勢分析
  • 製藥和生物技術公司
  • 學術研究機構
  • 合約研發/合約行銷

第7章 區域業務分析

  • RNAi技術市場佔有率：按地區分類，2025年和2033年
  • 北美洲
    • 2021-2033年北美RNAi技術市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲RNAi技術市場，2021-2033年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區RNAi技術市場，2021-2033年
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2021-2033年拉丁美洲RNAi技術市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東及非洲RNAi技術市場
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 公司分類
  • 策略規劃
  • 企業市場占有率及定位分析，2025年
  • 公司簡介列表
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Creative Biolabs
    • GenScript
    • Revvity
    • Promega Corporation
    • OriGene Technologies, Inc.
    • Altogen Biosystems
    • Danaher
    • Bioneer Corporation
Product Code: GVR-4-68040-295-6

RNAi Technology Market Summary

The global RNAi technology market size was valued at USD 3.3 billion in 2025 and is projected to grow from USD 3.7 billion in 2026 to USD 9.5 billion by 2033, at a CAGR of 14.6% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 38.3% in 2025. The market growth can be attributed to the increasing prevalence of autoimmune diseases, rare disorders, and cancer across the globe.

Global RNAi Technology Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global RNAi technology market report based on product & service, application, end use, and region:

  • Product & Service Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Products
    • siRNA products
    • miRNA products
    • Others
  • Services
  • Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Drug Discovery & Development
    • Neurology
    • Oncology
    • Infectious Diseases
    • Metabolic Diseases
    • Others
  • Functional Genomics
  • Others
  • End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • CROs & CMOs
  • Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Products & Service Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. List of Secondary Sources
    • 1.9.3. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements in RNAi Techniques
      • 3.2.1.2. Increasing Application of RNAi Technology in Research and Medicine
      • 3.2.1.3. Growing Demand for Precision Therapeutics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Development and Manufacturing Costs
      • 3.2.2.2. Challenges Associated with Efficient RNAi Delivery Systems
      • 3.2.2.3. Off-Target Effects and Safety Concerns
    • 3.2.3. Market Opportunities Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTLE Analysis

Chapter 4. Product & Service Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. RNAi Technology Market: Product & Service Movement Analysis
  • 4.3. Products
    • 4.3.1. Products Market, 2021-2033 (USD Million/Billion)
    • 4.3.2. siRNA Products
      • 4.3.2.1. siRNA Products Market, 2021-2033 (USD Million/Billion)
    • 4.3.3. miRNA Products
      • 4.3.3.1. miRNA Products Market, 2021-2033 (USD Million/Billion)
    • 4.3.4. Others
      • 4.3.4.1. Others Market, 2021-2033 (USD Million/Billion)
  • 4.4. Services
    • 4.4.1. Services Market, 2021-2033 (USD Million/Billion)

Chapter 5. Application Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. RNAi Technology Market: Application Movement Analysis
  • 5.3. Drug Discovery & Development
    • 5.3.1. Drug Discovery & Development Market, 2021-2033 (USD Million/Billion)
    • 5.3.2. Neurology
      • 5.3.2.1. Neurology Market, 2021-2033 (USD Million/Billion)
    • 5.3.3. Oncology
      • 5.3.3.1. Oncology Market, 2021-2033 (USD Million/Billion)
    • 5.3.4. Infectious Diseases
      • 5.3.4.1. Infectious Diseases Market, 2021-2033 (USD Million/Billion)
    • 5.3.5. Metabolic Diseases
      • 5.3.5.1. Metabolic Diseases Market, 2021-2033 (USD Million/Billion)
    • 5.3.6. Others
      • 5.3.6.1. Others Market, 2021-2033 (USD Million/Billion)
  • 5.4. Functional Genomics
    • 5.4.1. Functional Genomics Market, 2021-2033 (USD Million/Billion)
  • 5.5. Others
    • 5.5.1. Others Market, 2021-2033 (USD Million/Billion)

Chapter 6. End Use Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. RNAi Technology Market: End Use Movement Analysis
  • 6.3. Pharmaceutical & Biotechnology Companies
    • 6.3.1. Pharmaceutical & Biotechnology Companies Market, 2021-2033 (USD Million/Billion)
  • 6.4. Academic & Research Institutes
    • 6.4.1. Academic & Research Institutes Market, 2021-2033 (USD Million/Billion)
  • 6.5. CROs & CMOs
    • 6.5.1. CROs & CMOs Market, 2021-2033 (USD Million/Billion)

Chapter 7. Regional Business Analysis

  • 7.1. RNAi Technology Market Share By Region, 2025 & 2033
  • 7.2. North America
    • 7.2.1. North America RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Mexico RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
  • 7.3. Europe
    • 7.3.1. Europe RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Thailand RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
  • 7.5. Latin America
    • 7.5.1. Latin America RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Argentina RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
  • 7.6. MEA
    • 7.6.1. MEA RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE RNAi Technology Market, 2021 - 2033 (USD Million/Billion)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait RNAi Technology Market, 2021 - 2033 (USD Million/Billion)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share/ Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Creative Biolabs
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Revvity
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Promega Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. OriGene Technologies, Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Altogen Biosystems
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Danaher
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Bioneer Corporation
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 4 Global RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 5 Global RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 6 Global RNAi technology market, by region, 2021 - 2033 (USD Million/Billion)
  • Table 7 North America RNAi technology market, by country, 2021 - 2033 (USD Million/Billion)
  • Table 8 North America RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 9 North America RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 10 North America RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 11 U.S. RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 12 U.S. RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 13 U.S. RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 14 Canada RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 15 Canada RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 16 Canada RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 17 Mexico RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 18 Mexico RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 19 Mexico RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 20 Europe RNAi technology market, by country, 2021 - 2033 (USD Million/Billion)
  • Table 21 Europe RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 22 Europe RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 23 Europe RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 24 UK RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 25 UK RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 26 UK RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 27 Germany RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 28 Germany RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 29 Germany RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 30 France RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 31 France RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 32 France RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 33 Italy RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 34 Italy RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 35 Italy RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 36 Spain RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 37 Spain RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 38 Spain RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 39 Denmark RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 40 Denmark RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 41 Denmark RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 42 Sweden RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 43 Sweden RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 44 Sweden RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 45 Norway RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 46 Norway RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 47 Norway RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 48 Asia Pacific RNAi technology market, by country, 2021 - 2033 (USD Million/Billion)
  • Table 49 Asia Pacific RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 50 Asia Pacific RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 51 Asia Pacific RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 52 Japan RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 53 Japan RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 54 Japan RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 55 China RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 56 China RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 57 China RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 58 India RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 59 India RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 60 India RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 61 Australia RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 62 Australia RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 63 Australia RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 64 Thailand RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 65 Thailand RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 66 Thailand RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 67 South Korea RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 68 South Korea RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 69 South Korea RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 70 Latin America RNAi technology market, by country, 2021 - 2033 (USD Million/Billion)
  • Table 71 Latin America RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 72 Latin America RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 73 Latin America RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 74 Brazil RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 75 Brazil RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 76 Brazil RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 77 Argentina RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 78 Argentina RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 79 Argentina RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 80 Middle East & Africa RNAi technology market, by country, 2021 - 2033 (USD Million/Billion)
  • Table 81 Middle East & Africa RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 82 Middle East & Africa RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 83 Middle East & Africa RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 84 South Africa RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 85 South Africa RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 86 South Africa RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 87 Saudi Arabia RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 88 Saudi Arabia RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 89 Saudi Arabia RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 90 UAE RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 91 UAE RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 92 UAE RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)
  • Table 93 Kuwait RNAi technology market, by product & service, 2021 - 2033 (USD Million/Billion)
  • Table 94 Kuwait RNAi technology market, by application, 2021 - 2033 (USD Million/Billion)
  • Table 95 Kuwait RNAi technology market, by end use, 2021 - 2033 (USD Million/Billion)

List of Figures

  • Fig. 1 RNAi technology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 RNAi technology market driver analysis
  • Fig. 12 RNAi technology market restraint analysis
  • Fig. 13 RNAi technology market: Porter's five forces analysis
  • Fig. 14 RNAi technology market: PESTLE analysis
  • Fig. 15 RNAi technology market: Product & Service outlook and key takeaways
  • Fig. 16 RNAi technology market: Product & Service market share analysis
  • Fig. 17 Products market, 2021 - 2033 (USD Million/Billion)
  • Fig. 18 miRNA products market, 2021 - 2033 (USD Million/Billion)
  • Fig. 19 siRNA products market, 2021 - 2033 (USD Million/Billion)
  • Fig. 20 Others market, 2021 - 2033 (USD Million/Billion)
  • Fig. 21 Services market, 2021 - 2033 (USD Million/Billion)
  • Fig. 22 RNAi technology market: Application outlook and key takeaways
  • Fig. 23 RNAi technology market: Application market share analysis
  • Fig. 24 Drug discovery & development market, 2021 - 2033 (USD Million/Billion)
  • Fig. 25 Neurology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 26 Oncology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 27 Infectious diseases market, 2021 - 2033 (USD Million/Billion)
  • Fig. 28 Metabolic diseases market, 2021 - 2033 (USD Million/Billion)
  • Fig. 29 Others market, 2021 - 2033 (USD Million/Billion)
  • Fig. 30 Functional genomics market, 2021 - 2033 (USD Million/Billion)
  • Fig. 31 Others market, 2021 - 2033 (USD Million/Billion)
  • Fig. 32 RNAi technology market: End use outlook and key takeaways
  • Fig. 33 RNAi technology market: End use market share analysis
  • Fig. 34 Pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million/Billion)
  • Fig. 35 Academic & research institutes market, 2021 - 2033 (USD Million/Billion)
  • Fig. 36 CROs & CMOs market, 2021 - 2033 (USD Million/Billion)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America RNAi technology market, by country, 2021 -2033 (USD Million/Billion)
  • Fig. 39 U.S. RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 40 Canada RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 41 Mexico RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 42 Europe RNAi technology market, by country, 2021 -2033 (USD Million/Billion)
  • Fig. 43 UK RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 44 Germany RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 45 France RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 46 Italy RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 47 Spain RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 48 Denmark RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 49 Sweden RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 50 Norway RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 51 Asia-Pacific RNAi technology market, by country, 2021 -2033 (USD Million/Billion)
  • Fig. 52 Japan RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 53 China RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 54 India RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 55 Australia RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 56 Thailand RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 57 South Korea RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 58 Latin America RNAi technology market, by country, 2021 -2033 (USD Million/Billion)
  • Fig. 59 Brazil RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 60 Argentina RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 61 MEA RNAi technology market, by country, 2021 -2033 (USD Million/Billion)
  • Fig. 62 South Africa RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 63 Saudi Arabia RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 64 UAE RNAi technology market, 2021 - 2033 (USD Million/Billion)
  • Fig. 65 Kuwait RNAi technology market, 2021 - 2033 (USD Million/Billion)